I

Invivyd
D

IVVD

1.03000
USD
0.11
(12.04%)
مغلق
حجم التداول
47,085
الربح لكل سهم
0
العائد الربحي
0
P/E
-1
حجم السوق
123,025,914
الأخبار المقالات

العنوان: Invivyd

القطاع: Healthcare
الصناعة: Biotechnology
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.